Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
Francolla
Karen A
KA
Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, USA.
Altman
Arnold
A
Sylvester
Francisco A
FA
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis* / Q000209:etiology / Q000821:virology*; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D012367:RNA, Viral; D000069285:Infliximab; D001379:Azathioprine